Details

Notice of Amendment: Revision of Brimonidine on the Prescription Drug List (PDL) - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Mar 2, 2026 · edition #6
Timestamp: 2026-03-02T19:20:30.426Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/amendment-revision-brimonidine.html
Replay URL: https://replay.healtharchive.ca/job-6/20260302192030/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/amendment-revision-brimonidine.html#ha_snapshot=616320
ID: 616320
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots